2016 DISRUPT-CAD success Shockwave
<p>Nov 03, 2016 05:14 PM stunning result!</p>
<p>
wow!</p>
<p>
has had recent FDA approval for PAD. will release system in 2017.</p>
<p>
this trail is DISRUPT-CAD 60 patients.</p>
<p>
clinical success in 57 of 60 patients!!! 95%</p>
<p>
defn is residual stenosis of < 50% pst-PCI with no MACE.</p>
<p>
device success of 98% (59 of 60 pts)</p>
<p>
combo balloon + lithotripsy.</p>
<p>
lesion lengths < 32 mm and ref vessel diameter from 2.5 to 4 mm.</p>
<p>
stenosis dropped from 68% diam to 13% after
and lumen diameter incr fro 0.9 to 2.6 mm post PCI.</p>
<p>
lumen area incr from 2.2 mm2 pre PCI to 6 mm2 post-PCI.</p>
<p>
</p>
<p>
</p>